Faqja kryesoreRHHBY • OTCMKTS
add
Roche Holdings AG Basel ADR Common Stock
34,67 USD
Pas orarit:(0,00%)0,00
34,67 USD
Mbyllur: 28 qer, 4:01:33 e pasdites, GMT-4 · USD · OTCMKTS · Mohimi i përgjegjësisë
Mbyllja e fundit
34,91 USD
Diapazoni ditor
34,56 USD - 34,82 USD
Diapazoni vjetor
29,20 USD - 39,92 USD
Kapitalizimi i tregut
227,60 mld USD
Volumi mesatar
2,61 mln
Lajmet nga tregu
Financa
Deklarimi mbi të ardhurat
Të ardhurat
Të ardhurat neto
(CHF) | dhj 2023info | Ndryshimi nga V/V |
---|---|---|
Të ardhurat | 14,91 mld | -6,55% |
Kostoja operative | 7,36 mld | -0,92% |
Të ardhurat neto | 2,18 mld | 12,08% |
Marzhi i fitimit neto | 14,62 | 19,93% |
Fitimet për aksion | — | — |
EBITDA | 4,34 mld | -14,44% |
Norma efektive tatimore | 2,24% | — |
Bilanci
Aktivet në total
Pasivet në total
(CHF) | dhj 2023info | Ndryshimi nga V/V |
---|---|---|
Investime afatshkurtra dhe në para fizike | 10,51 mld | 7,62% |
Aktivet në total | 90,47 mld | 2,63% |
Pasivet në total | 57,20 mld | 1,90% |
Kapitali aksioner në total | 33,26 mld | — |
Numri i aksioneve të aksionerëve | 797,24 mln | — |
Çmimi për të rezervuar | 0,95 | — |
Kthimi nga aktivet | 9,85% | — |
Kthimi nga kapitali | 13,90% | — |
Fluksi i parave
Ndryshimi neto i parave në dorë
(CHF) | dhj 2023info | Ndryshimi nga V/V |
---|---|---|
Të ardhurat neto | 2,18 mld | 12,08% |
Paratë nga veprimtaritë | 4,10 mld | -5,04% |
Paratë nga investimi | -5,08 mld | -114,59% |
Paratë nga financimi | 2,03 mld | 236,96% |
Ndryshimi neto i parave në dorë | 828,00 mln | 144,97% |
Fluksi i lirë i parave | 1,84 mld | -24,58% |
Informacione
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76.
The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States-based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021. Roche is one of the few companies increasing their dividend every year, for 2020 as the 34th consecutive year.
F. Wikipedia
Drejtori ekzekutiv
Themeluar
1 tet 1896
Zyrat qendrore
Faqja në internet
Punonjësit
103 605